Highlights Xenetic Biosciences, Inc.

Equities

XBIO

US9840156023

Market Closed - Nasdaq Other stock markets 04:30:01 2024-05-16 pm EDT			5-day change	1st Jan Change
3.55 ^USD	-10.25%		-12.17%	+2.90%

May. 09	Xenetic Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 21	Xenetic Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Xenetic Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
Xenetic Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21	CI
Xenetic Biosciences, Inc. Enters into Research Agreement with the University of Virginia for the Advancement of Its DNase-Based Oncology Platform	Jan. 17	CI
Xenetic Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Xenetic Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Xenetic Biosciences to Implement 1-for-10 Reverse Split	23-05-12	MT
Xenetic Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
Xenetic Biosciences, The Scripps Research Institute Enter Into Research Collaboration	23-04-11	MT
Xenetic Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-09	CI
Xenetic Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
Xenetic Biosciences Signs Manufacturing Deal With Catalent Unit for Cancer Platform	22-07-07	MT
Xenetic Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
Xenetic Biosciences, Inc. Enters into Sublicense Agreement with CLS Therapeutics Ltd	22-04-27	CI
Xenetic Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-22	CI
Xenetic Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-12	CI
Xenetic Biosciences, Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2021	21-08-12	CI
Xenetic Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-11	CI
Xenetic Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-16	CI
Midday Report: Wall Street Softer, Key Indexes Retreats From Record Highs; DoorDash Makes Strong Debut	20-12-09	MT
Xenetic Biosciences, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Xenetic Biosciences, Inc.

Equities

XBIO

US9840156023

Highlights

Filters